Trying Times at the FDA — The Challenge of Ensuring the Safety of Imported Pharmaceuticals  

Oleh:

Schweitzer, Stuart O.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 358 no. 17 (Apr. 2008), page 1773.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In recent years, the Food and Drug Administration (FDA) has faced three serious challenges to its ability to ensure the safety of the country's medical devices and drugs. The first arose when the widely marketed drug Vioxx (rofecoxib) was shown to be dangerous enough for its manufacturer to withdraw it from the market. Previously, consumers and most physicians had assumed that the FDA's drug-approval process, though not legally guaranteeing a product's safety, could be trusted to assure the public of its relative safety. The challenge to physicians, who were forced to confront their prescribing habits, was no less than that . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali